29458298|t|beta-amyloid inhibits hippocampal LTP through TNFR/IKK/NF-kappaB pathway.
29458298|a|Objective The suppressive action of the acute application of oligomeric amyloid-beta (Abeta) on hippocampal long-term potentiation (LTP) has been reported widely. Many mechanisms have been proposed for Abeta inhibited LTP induction. The inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) has also been reported to play a key role in this LTP inhibition through Abeta. However, the underlying molecular mechanisms are largely unknown. This study aimed to investigate the link between Abeta- and TNF-alpha-mediated hippocampal LTP inhibition. Methods Acute hippocampal slices of male wildtype or Alzheimer's disease (AD) transgenic mouse models were treated with the inhibitors of either TNF-alpha, IkappaB Kinase (IKK) or Nuclear Factor-kappaB (NF-kappaB) in the presence or absence of oligomeric Abeta42 (500 nM/2 h). The LTP was assessed using field excitatory post synaptic potential recordings (fEPSP), and immunoblotting was used to evaluate the expression of IKK and NF-kappaB. Results Acute treatment with Abeta or TNF-alpha alone inhibited LTP and increased the phosphorylation of IKK and NF-kappaB in wild type mouse hippocampal slices. Pretreatment with TNF-alpha antagonist infliximab rescued the LTP impairment by Abeta and also restored the levels of IKK and NF-kappaB to the control levels. In addition, pretreatment with IKK2 IV or JSH23 also restored the Abeta-mediated LTP impairment. Furthermore, AD transgenic mouse hippocampal slices treated with infliximab or inhibitors of IKK or NF-kappaB showed improved LTP and reversed the activation of IKK and NF-kappaB. Conclusion In conclusion, our observations suggest that the IKK/NF-kappaB signaling pathway play an important role in Abeta-mediated hippocampal LTP impairment. Abeta might modulate IKK/NF-kappaB activity by binding or activating tumor necrosis factor receptor (TNFR).
29458298	46	50	TNFR	Gene	21937
29458298	55	64	NF-kappaB	Gene	18033
29458298	160	165	Abeta	Gene	11820
29458298	276	281	Abeta	Gene	11820
29458298	311	323	inflammatory	Disease	MESH:D007249
29458298	333	360	tumor necrosis factor-alpha	Gene	21926
29458298	362	371	TNF-alpha	Gene	21926
29458298	446	451	Abeta	Gene	11820
29458298	568	573	Abeta	Gene	11820
29458298	579	588	TNF-alpha	Gene	21926
29458298	679	698	Alzheimer's disease	Disease	MESH:D000544
29458298	700	702	AD	Disease	MESH:D000544
29458298	715	720	mouse	Species	10090
29458298	771	780	TNF-alpha	Gene	21926
29458298	806	827	Nuclear Factor-kappaB	Gene	18033
29458298	829	838	NF-kappaB	Gene	18033
29458298	1057	1067	NF-kappaB.	Gene	18033
29458298	1097	1102	Abeta	Gene	11820
29458298	1106	1115	TNF-alpha	Gene	21926
29458298	1181	1190	NF-kappaB	Gene	18033
29458298	1204	1209	mouse	Species	10090
29458298	1248	1257	TNF-alpha	Gene	21926
29458298	1269	1279	infliximab	Chemical	MESH:D000069285
29458298	1310	1315	Abeta	Gene	11820
29458298	1356	1365	NF-kappaB	Gene	18033
29458298	1431	1436	JSH23	Chemical	MESH:C549066
29458298	1455	1460	Abeta	Gene	11820
29458298	1499	1501	AD	Disease	MESH:D000544
29458298	1513	1518	mouse	Species	10090
29458298	1551	1561	infliximab	Chemical	MESH:D000069285
29458298	1586	1595	NF-kappaB	Gene	18033
29458298	1655	1665	NF-kappaB.	Gene	18033
29458298	1730	1739	NF-kappaB	Gene	18033
29458298	1784	1789	Abeta	Gene	11820
29458298	1827	1832	Abeta	Gene	11820
29458298	1852	1861	NF-kappaB	Gene	18033
29458298	1896	1926	tumor necrosis factor receptor	Gene	21937
29458298	1928	1932	TNFR	Gene	21937
29458298	Association	MESH:D000069285	11820
29458298	Association	MESH:D007249	11820
29458298	Association	11820	21937
29458298	Positive_Correlation	18033	21926
29458298	Association	MESH:D000544	18033
29458298	Association	18033	21937
29458298	Association	MESH:C549066	11820
29458298	Association	11820	21926
29458298	Negative_Correlation	MESH:D000069285	21926
29458298	Negative_Correlation	MESH:D000069285	18033
29458298	Negative_Correlation	MESH:D000069285	MESH:D000544
29458298	Positive_Correlation	11820	18033

